During the past decade, SJH Cardiology Associates conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 6 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "SJH Cardiology Associates" #1 sponsor was "Pfizer" with 3 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored, "Amgen" with 1 trials sponsored and "Baim Institute for Clinical Research" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "SJH Cardiology Associates" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Baim Institute for Clinical Research" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "SJH Cardiology Associates" are "Cardiovascular Disease" (2 trials), "Coronary Artery Disease" (2 trials), "ASCVD" (1 trials), "Angina Pectoris" (1 trials) and "Angioplasty, Transluminal, Percutaneous Coronary" (1 trials). Many other conditions were trialed in "SJH Cardiology Associates" in a lesser frequency.

Most popular intervention types in "SJH Cardiology Associates" are "Drug" (9 trials), "Device" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "bococizumab (PF-04950615)" (2 trials), "Actual device PFO closure" (1 trials), "Apixaban" (1 trials) and "Bococizumab (PF-04950615; RN316)" (1 trials). Other intervention names were less common.

The vast majority of trials in "SJH Cardiology Associates" are 13 trials for "All" genders.

Currently, there are NaN active trials in "SJH Cardiology Associates". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in SJH Cardiology Associates, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in SJH Cardiology Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".